MedTrace Logo

Strategy for Uptake of Processes for Recognizing and Responding to Acute Kidney Injury

NCT03564314 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2135

Last updated 2023-11-28

No results posted yet for this study

Summary

Acute kidney injury (AKI) is common and costly complication of major surgery. AKI can lead to prolonged hospitalization and a higher likelihood of dialysis, chronic kidney disease and death. However, AKI can be reversed when recognized early, by ensuring that patients receive adequate fluids and medications that worsen kidney function or cause toxicity are avoided or appropriately prescribed. Past research suggests that AKI in surgical settings can be missed early in its onset, leading to delayed intervention and progression to more severe stages. The purpose of this project is to implement clinical decision support for early recognition and management of AKI on surgical units in Alberta hospitals, and to determine whether the initiative leads to improvements in the quality of care for AKI, length of hospital stay for patients, and costs to the healthcare system.

Conditions

Interventions

OTHER

SUPPORT AKI Clinical Decision Support

Surgical units will receive a multidimensional clinical decision support intervention consisting of: (1) electronic and non-computerized tools to alert for early recognition of AKI, (2) educational program for physicians and nursing staff, (3) decision support tools with guidance on fluid therapies, medication management, investigations for AKI, and consultation with specialists.

Sponsors & Collaborators

  • Alberta Health services

    collaborator OTHER

  • University of Alberta

    collaborator OTHER

  • Covenant Health, Canada

    collaborator OTHER

  • University of Calgary

    lead OTHER

Principal Investigators

  • Matthew T James, MD, PhD · Associate Professor

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-13
Primary Completion
2020-01-31
Completion
2020-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03564314 on ClinicalTrials.gov